Suppression of thyroglobulin secretion in amiodarone iodine-induced thyrotoxicosis
- 1 January 1988
- journal article
- case report
- Published by Springer Nature in Journal of Endocrinological Investigation
- Vol. 11 (1) , 53-55
- https://doi.org/10.1007/bf03350098
Abstract
A 41-year-old male patient developed amiodarone-induced thyrotoxicosis after 29 months of treatment with amiodarone. Thyrotoxicosis was readily reversible after cessation of the drug and did not need specific thyrostatic treatment. In contrast to what was expected, thyroglobulin serum concentrations, that were normal during the first 2 yr of follow up, decreased drastically to undetectable levels during and after the thyrotoxic phase. Although no explanation can be offered for this phenomenon, it seems important to point out the fact that measurement of thyroglobulin is of only limited value in the diagnosis of thyroid dysfunction in patients treated with amiodarone. Low levels do not exclude thyrotoxicosis.Keywords
This publication has 6 references indexed in Scilit:
- AMIODARONE IODINE‐INDUCED HYPOTHYROIDISM: RISK FACTORS AND FOLLOW‐UP IN 28 CASESClinical Endocrinology, 1987
- IS HUMORAL THYROID AUTOIMMUNITY RELEVANT IN AMIODARONE IODINE‐INDUCED THYROTOXICOSTS (AIIT)?Clinical Endocrinology, 1986
- AMIODARONE-INDUCED THYROTOXICOSIS1986
- Antithyroid antibodies as an early marker for thyroid disease induced by amiodarone.BMJ, 1986
- Environmental Iodine Intake and Thyroid Dysfunction During Chronic Amiodarone TherapyAnnals of Internal Medicine, 1984
- Low Serum Thyroglobulin as a Clue to the Diagnosis of Thyrotoxicosis FactitiaNew England Journal of Medicine, 1982